A study to look at the effects of a new medicine (astegolimab) in comparison to placebo - in patients with eczema (atopic dermatitis)
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis
-
Autoimmune Disorder -
Atopic Dermatitis
For the latest version of this information please go to www.forpatients.roche.com